TEGยฎ, Microclot and Platelet Mapping for Guiding Early Management of Severe COVID-19 Coagulopathy ncbi.nlm.nih.gov/pmc/artiโ€ฆ
๐Ÿ‘︎ 13
๐Ÿ’ฌ︎
๐Ÿ“…︎ Jan 06 2022
๐Ÿšจ︎ report
WARNING: Hillsborough County, Florida DOH investigating multiple reports of coagulopathy after smoking synthetic blends

"HILLSBOROUGH COUNTY, Fla. โ€” The Department of Health is investigating multiple reports of people becoming "severely ill" after smoking synthetic blends"

"These individuals displayed symptoms associated with coagulopathy, a condition where the blood's ability to clot is impaired," DOH-Hillsborough said in a press release. "While the symptoms reported have varied, most cases have had bruising, nosebleeds, bleeding gums, vomiting blood, blood in urine or stool, and heavy menstrual bleeding."

DOH-Hillsborough said if you or anyone you know exhibits symptoms after smoking spice you should call 911 immediately.

"The department is working to identify and investigate possible cases, and is coordinating with hospitals, emergency medical services, and other healthcare providers to keep an eye out for other potential patients."

There was a very similar incident also in Hillsborough Country Florida back in 2018 and brodifacoum was confirmed in samples then, however there is no information in regards to this specific incident as of yet. This new incident just occurred this week.

I have no idea why someone would use brodifacoum unless it was a mis-synth of a structurally related coumarin cannabinoid being identified/assumed as brodifacoum because it's also a coumarin.

Regardless please be aware and use extra caution and be aware of the symptoms of coagulopathy.

UPDATE: 2 people have died directly linked to this new incident with 41+ hospitalized. Reportedly spreading throughout Florida but mainly Hillsborough.

https://www.tampabay.com/news/health/2021/12/15/2-dead-41-hospitalized-in-hillsborough-from-poisonous-batch-of-spice/

๐Ÿ‘︎ 6
๐Ÿ’ฌ︎
๐Ÿ‘ค︎ u/cannabiphorol
๐Ÿ“…︎ Dec 11 2021
๐Ÿšจ︎ report
AGA (The American Gastroenterological Association), has issued a new set of guidelines to diagnose and manage coagulopathies in cirrhosis patients. journal.medizzy.com/agas-โ€ฆ
๐Ÿ‘︎ 18
๐Ÿ’ฌ︎
๐Ÿ‘ค︎ u/Emergentelman
๐Ÿ“…︎ Nov 08 2021
๐Ÿšจ︎ report
Coagulopathy in SARS-CoV-2 Infected Patients: Implication for the Management of COVID-19 dovepress.com/coagulopathโ€ฆ
๐Ÿ‘︎ 4
๐Ÿ’ฌ︎
๐Ÿ‘ค︎ u/icloudbug
๐Ÿ“…︎ Aug 03 2021
๐Ÿšจ︎ report
COVID-19-associated coagulopathy and antithrombotic agentsโ€”lessons after 1 year thelancet.com/journals/laโ€ฆ
๐Ÿ‘︎ 17
๐Ÿ’ฌ︎
๐Ÿ‘ค︎ u/icloudbug
๐Ÿ“…︎ Apr 28 2021
๐Ÿšจ︎ report
Immunity, endothelial injury and complement-induced coagulopathy in COVID-19 nature.com/articles/s4158โ€ฆ
๐Ÿ‘︎ 9
๐Ÿ’ฌ︎
๐Ÿ‘ค︎ u/icloudbug
๐Ÿ“…︎ Oct 24 2020
๐Ÿšจ︎ report
Platelet Activating Immune Complexes Identified in COVID-19 Associated Coagulopathy medrxiv.org/content/10.11โ€ฆ
๐Ÿ‘︎ 7
๐Ÿ’ฌ︎
๐Ÿ‘ค︎ u/icloudbug
๐Ÿ“…︎ Nov 06 2020
๐Ÿšจ︎ report
COVID-19-Related Coagulopathyโ€”Is Transferrin a Missing Link? mdpi.com/2075-4418/10/8/5โ€ฆ
๐Ÿ‘︎ 8
๐Ÿ’ฌ︎
๐Ÿ‘ค︎ u/1130wien
๐Ÿ“…︎ Oct 24 2020
๐Ÿšจ︎ report
Integral Use of Thromboelastography With Platelet Mapping to Guide Appropriate Treatment, Avoid Complications, and Improve Survival of Patients With Coronavirus Disease 2019โ€“Related Coagulopathy perfusion.com/integral-usโ€ฆ
๐Ÿ‘︎ 2
๐Ÿ’ฌ︎
๐Ÿ‘ค︎ u/PerfusionCom
๐Ÿ“…︎ Mar 18 2021
๐Ÿšจ︎ report
Autopsy Findings and Blood Clots in COVID-19 Patients: Autopsy revealed deep venous thrombosis in 58% of patients in whom venous thromboembolism was not suspected before death. The high incidence of thromboembolic events suggests an important role of COVID-19โ€“induced coagulopathy. annals.org/aim/fullarticlโ€ฆ
๐Ÿ‘︎ 3
๐Ÿ’ฌ︎
๐Ÿ‘ค︎ u/worldnewsbot
๐Ÿ“…︎ May 11 2020
๐Ÿšจ︎ report
Coagulopathy of trauma

I'll try this again for y'all. Little bit of background, I post this stuff on my Instagram: @fisherad1. Y'all know there is character limits, which may be why there is a bit of disconnect. I do this because I publish a lot of articles and read a lot, many in EMS or military medicine do not have the same access as I, so I try to share a little bit, given character limits. I enjoy spreading knowledge about trauma care. This is not something I have to do or an assignment. Some of your comments were useful, thank you.

Three types of coagulopathy in hemorrhagic shock.

  1. Trauma Induced Coagulopathy
  2. Acute Traumatic Coagulopathy
  3. Iatrogenic Coagulopathy

The iatrogenic coagulopathy (lethal triad) is a combination of coagulopathy, acidosis, and hypothermia, where each is the result of and cause of the others. The lethal triad is also referred to as iatrogenic due to crystalloid administration and poor hypothermia prevention. For many years, the best defense against the lethal triad in prehospital medicine was hypothermia prevention. More recently, there has been a resurgence of using whole blood to address the coagulopathy and acidosis. The lethal triad is preventable if we treat our patients with an evidenced based approach. However, the lethal triad is only a partial cause of shock. Trauma induced coagulopathy (TIC) is the overarching theme and can happen anytime after injury.[1] Where acute traumatic coagulopathy (ATC) happens within 30 min after the injury. While the lethal triad is part of the exogenous pathway, (ATC) is an endogenous arm and far more complicated. The drivers of ATC are poorly understood by many physicians and scientists, but there are basic mechanisms that are universal.

ATC was first described in 2003 by Brohi et al. [2] They found that approximately 25% of severely injured patients presented with ATC and it could exacerbate the hemorrhage. ATC was associated with functional reductions in clot generation and clot strength, consumption of coagulation factors, systemic anticoagulation, and hyperfibrinolysis.[2,3]

Using laboratory data, ATC is defined and characterized by reduction in clot generation and strength, as well as minor prolonged clotting timesโ€”prothrombin time (PT) >18 seconds, partial activated thromboplastin time (aPTT) >60 seconds, and thrombin time (TT) >15 seconds.[2,4]

Hyperfibrino

... keep reading on reddit โžก

๐Ÿ‘︎ 50
๐Ÿ’ฌ︎
๐Ÿ‘ค︎ u/FisherAD1
๐Ÿ“…︎ Nov 15 2019
๐Ÿšจ︎ report
Coagulopathy of Coronavirus Disease 2019 pdfs.journals.lww.com/ccmโ€ฆ
๐Ÿ‘︎ 16
๐Ÿ’ฌ︎
๐Ÿ‘ค︎ u/GallantIce
๐Ÿ“…︎ Jun 21 2020
๐Ÿšจ︎ report
Coagulopathy in liver disease

In pathoma it mentions a similar picture to dic with some changes and something to do with decreased anti plasmin.. Can someone please explain it? I can't go back to the lectures and can't make sense of what I've noted

Thank you ๐Ÿ˜ญ

๐Ÿ‘︎ 2
๐Ÿ’ฌ︎
๐Ÿ‘ค︎ u/Verytired32
๐Ÿ“…︎ Sep 27 2020
๐Ÿšจ︎ report
Pyridoxal 5'-phosphate to mitigate immune dysregulation and coagulopathy in COVID-19 preprints.org/manuscript/โ€ฆ
๐Ÿ‘︎ 13
๐Ÿ’ฌ︎
๐Ÿ‘ค︎ u/D-R-AZ
๐Ÿ“…︎ May 14 2020
๐Ÿšจ︎ report
COVID-19 Coagulopathy in Caucasian patients researchgate.net/publicatโ€ฆ
๐Ÿ‘︎ 4
๐Ÿ’ฌ︎
๐Ÿ‘ค︎ u/D-R-AZ
๐Ÿ“…︎ Jun 01 2020
๐Ÿšจ︎ report
Pesquisa com anticoagulante - Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy

Publicaรงรฃo no link. O que acham dessa publicaรงรฃo?

https://onlinelibrary.wiley.com/doi/abs/10.1111/jth.14817

๐Ÿ‘︎ 3
๐Ÿ’ฌ︎
๐Ÿ‘ค︎ u/fvmb42
๐Ÿ“…︎ Apr 05 2020
๐Ÿšจ︎ report
Comparison of published guidelines for management of coagulopathy and thrombosis in critically ill patients with COVID 19: implications for clinical practice and future investigations ccforum.biomedcentral.comโ€ฆ
๐Ÿ‘︎ 6
๐Ÿ’ฌ︎
๐Ÿ‘ค︎ u/icloudbug
๐Ÿ“…︎ Sep 22 2020
๐Ÿšจ︎ report
Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia thelancet.com/action/showโ€ฆ
๐Ÿ‘︎ 24
๐Ÿ’ฌ︎
๐Ÿ‘ค︎ u/cloud_watcher
๐Ÿ“…︎ May 08 2020
๐Ÿšจ︎ report
Deaths due to Blood clots in COVID-19: Available evidence suggests that the coagulopathy associated with COVID-19 is a combination of low-grade DICโ€”disseminated blood clots within blood vesselsโ€”and localised clots in lungs. thelancet.com/journals/laโ€ฆ
๐Ÿ‘︎ 31
๐Ÿ’ฌ︎
๐Ÿ‘ค︎ u/Slydexia1952
๐Ÿ“…︎ May 12 2020
๐Ÿšจ︎ report
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19 nejm.org/doi/full/10.1056โ€ฆ
๐Ÿ‘︎ 19
๐Ÿ’ฌ︎
๐Ÿ‘ค︎ u/stereomatch
๐Ÿ“…︎ May 07 2020
๐Ÿšจ︎ report
Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia sciencedirect.com/scienceโ€ฆ
๐Ÿ‘︎ 15
๐Ÿ’ฌ︎
๐Ÿ‘ค︎ u/mobo392
๐Ÿ“…︎ May 08 2020
๐Ÿšจ︎ report
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19 nejm.org/doi/full/10.1056โ€ฆ
๐Ÿ‘︎ 9
๐Ÿ’ฌ︎
๐Ÿ‘ค︎ u/swingadmin
๐Ÿ“…︎ Apr 09 2020
๐Ÿšจ︎ report
Coagulopathy in Covid-19: Reviews and recommendations facs.org/-/media/files/coโ€ฆ
๐Ÿ‘︎ 16
๐Ÿ’ฌ︎
๐Ÿ‘ค︎ u/newredditacct1221
๐Ÿ“…︎ May 07 2020
๐Ÿšจ︎ report
Coagulopathies - cause of superficial vs deep bleeding?

I'm posting on here since I couldn't find any explanation on the net or in my books, hoping maybe someone here has a logical explanation!

Why do defects in platelets predominantly manifest as superficial bleeding (petechiae, purpura, or ecchymoses), while coagulation factor defects e.g. hemophilia mainly manifest as deep bleeding in the joints / internal organs?

Is there any scientific explanation to this preponderance or is it just a take it or leave it phenomenon?

TIA !

๐Ÿ‘︎ 9
๐Ÿ’ฌ︎
๐Ÿ‘ค︎ u/zws1995
๐Ÿ“…︎ Nov 20 2016
๐Ÿšจ︎ report
PulmCrit- TEG for cirrhotic coagulopathy: Time for clinical implementation? emcrit.org/pulmcrit/teg-cโ€ฆ
๐Ÿ‘︎ 4
๐Ÿ’ฌ︎
๐Ÿ‘ค︎ u/emcrit
๐Ÿ“…︎ Jun 17 2019
๐Ÿšจ︎ report
Regarding timing of IR intervention in spontaneous intramuscular hematoma in the setting of coagulopathy. Mini case description and discussion.

A couple weeks ago when I was working I had a decompensated cirrhotic (EtoH) present with LLQ pain and a spontaneous (per her history) intramuscular hematoma. Stable vital signs (although on BB), Hct down 10 pts from about a month ago (37 -> 27). plts ~100, INR about 2.7 if I recall correctly, BUN wasn't crazy but she had an AKI as well (Cr of 1.6-7 I think). In my experience IR usually isn't interested taking these patients for emergently for embolization until after the coagulopathy has had a chance to get better as sometimes these spontaneously resolve.

That night I gave her 10 mg IV vit K , FFP, typed and crossed her with the expectation that her hct would drop (which it did, to 24 by 6 AM and then 19 later that day), INR had corrected (but was probably transient at that time point). I was a little surprised the day team didn't consult IR at that point, but they did take her the day after when she continued to need blood and didn't find anything to embolize.

I was wondering in your institutions how often or quickly does IR try to embolize these patients and what has been your experience. From my N of 3-4 now (across several different hospitals), I find that IR is hesitant to take them unless they fail reversal of the coagulant and when they do they often don't find any active bleeding (presumably the hematoma snowballs and starts shearing slow venous bleeders that can't be embolized is how I have had it described to me). Most of my patients who present with this end up dying (including her, unfortunately) so I wonder what I could be doing better (perhaps putting more pressure on IR to immediately take the patient that night)? Any thoughts?

๐Ÿ‘︎ 15
๐Ÿ’ฌ︎
๐Ÿ‘ค︎ u/Herodotus38
๐Ÿ“…︎ Nov 20 2015
๐Ÿšจ︎ report
PulmCrit- Coagulopathy management in the bleeding cirrhotic: Seven pearls and one crazy idea emcrit.org/pulmcrit/coaguโ€ฆ
๐Ÿ‘︎ 6
๐Ÿ’ฌ︎
๐Ÿ‘ค︎ u/rhizomaticaxyz
๐Ÿ“…︎ Dec 07 2015
๐Ÿšจ︎ report

Please note that this site uses cookies to personalise content and adverts, to provide social media features, and to analyse web traffic. Click here for more information.